Your browser doesn't support javascript.
loading
[A Case of Diagnosed Lynch Syndrome in a Patient with Ureteral Cancer].
Kobayashi, Genki; Takayanagi, Akio; Shindo, Tetsuya; Hashimoto, Kohei; Kobayashi, Ko; Fukuta, Fumimasa; Tanaka, Toshiaki; Masumori, Naoya.
Afiliação
  • Kobayashi G; The Department of Urology, Sapporo Medical University School of Medicine.
  • Takayanagi A; The Department of Urology, Sapporo Medical University School of Medicine.
  • Shindo T; The Department of Urology, Sapporo Medical University School of Medicine.
  • Hashimoto K; The Department of Urology, Sapporo Medical University School of Medicine.
  • Kobayashi K; The Department of Urology, Sapporo Medical University School of Medicine.
  • Fukuta F; The Department of Urology, Sapporo Medical University School of Medicine.
  • Tanaka T; The Department of Urology, Sapporo Medical University School of Medicine.
  • Masumori N; The Department of Urology, Sapporo Medical University School of Medicine.
Hinyokika Kiyo ; 67(6): 229-232, 2021 Jun.
Article em Ja | MEDLINE | ID: mdl-34265897
ABSTRACT
Lynch syndrome (LS) is an autosomal dominant genetic disorder in which tumors are known to develop at an early age. Upper tract urothelial carcinoma is one of the tumors related to Lynch syndrome. A 49-year-old woman visited a urologic clinic due to left abdominal pain. She had a history of ovarian cancer. Her mother had a history of colorectal cancer and renal pelvic cancer, and her grandmother had had colorectal cancer. After detailed examination, she received laparoscopic left nephroureterectomy and she was pathologically diagnosed with left ureteral cancer. LS was suspected based on her past history, family history, and age. A microsatellite instability (MSI) test gave a positive result, and genetic analysis confirmed a mutation in the MSH2 gene, leading to the diagnosis of Lynch syndrome. Although LS has a high frequency of carcinogenesis, it is thought that an improved prognosis can be achieved by early discovery and treatment of cancer in LS patients. From our case report, we recommend screening of LS in patients with a past/family history, who have had an upper tract urothelial carcinoma. Once LS is diagnosed, the patient should be followed by a planned surveillance of cancer development.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ureterais / Neoplasias da Bexiga Urinária / Carcinoma de Células de Transição / Neoplasias Colorretais Hereditárias sem Polipose Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Female / Humans / Middle aged Idioma: Ja Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ureterais / Neoplasias da Bexiga Urinária / Carcinoma de Células de Transição / Neoplasias Colorretais Hereditárias sem Polipose Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Female / Humans / Middle aged Idioma: Ja Ano de publicação: 2021 Tipo de documento: Article